|
RPL18 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.51250001412251E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.13139999994239E-07 |
| Normal-vs-Stage2 |
3.983000E-03 |
| Normal-vs-Stage3 |
1.032690E-04 |
| Normal-vs-Stage4 |
1.178920E-04 |
| Stage1-vs-Stage2 |
6.774800E-01 |
| Stage1-vs-Stage3 |
2.917200E-01 |
| Stage1-vs-Stage4 |
8.828200E-04 |
| Stage2-vs-Stage3 |
2.264600E-01 |
| Stage2-vs-Stage4 |
3.216500E-04 |
| Stage3-vs-Stage4 |
1.121770E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.15319994956565E-09 |
| Normal-vs-AfricanAmerican |
1.70461999999816E-05 |
| Normal-vs-Asian |
5.439600E-02 |
| Caucasian-vs-AfricanAmerican |
8.149800E-01 |
| Caucasian-vs-Asian |
3.355800E-01 |
| AfricanAmerican-vs-Asian |
2.467800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.61610002736535E-09 |
| Normal-vs-Female |
2.96560000001556E-06 |
| Male-vs-Female |
3.595400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.81809999999905E-05 |
| Normal-vs-Extreme_Weight |
8.99269999576902E-08 |
| Normal-vs-Obese |
3.67960000025036E-07 |
| Normal-vs-Extreme_Obese |
1.308550E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.814600E-01 |
| Normal_Weight-vs-Obese |
3.086200E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.375650E-02 |
| Extreme_Weight-vs-Obese |
9.522200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.195020E-01 |
| Obese-vs-Extreme_Obese |
1.027360E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.405100E-04 |
| Normal-vs-Age(41-60Yrs) |
1.0020999996474E-07 |
| Normal-vs-Age(61-80Yrs) |
2.30910000009743E-07 |
| Normal-vs-Age(81-100Yrs) |
7.851900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.002200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.105500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.364200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.684800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.367800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.976400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.57390000424351E-08 |
| Normal-VS-Type2 PRCC |
2.638500E-04 |
| Normal-VS-KIRP CIMP |
2.560500E-04 |
| Normal-VS-Unclassified PRCC |
2.479400E-03 |
| Type1 PRCC-VS-Type2 PRCC |
6.016200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.31759999999426E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
4.657200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.156700E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
8.103400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.563070E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.48580000003395E-06 |
| Normal-vs-N1 |
4.59900000004954E-06 |
| Normal-vs-N2 |
7.11999999958302E-07 |
| N0-vs-N1 |
1.693530E-02 |
| N0-vs-N2 |
8.208100E-02 |
| N1-vs-N2 |
7.211000E-01 |
|
|
